Alcohol Use Disorder Outcomes A national cohort study in Denmark of 38,454 individuals showed that GLP-1 medications were associated with a reduced risk of alcohol-related outcomes after three months of treatment, which included fewer hospitalizations, registered alcohol use disorder treatment, and purchase of medications to manage alcohol withdrawal (Wium-Andersen et al., 2022)
This point cannot be overstated
The modest increase in heart rate associated with semaglutide may be a consideration in patients with compromised cardiac function
He prescribes GLP-1 drugs, and he's candid about their limits
Thats hard to deliver in standard PCP visits
This medication is offered as part of a broader, clinically supervised weight management program that prioritizes patient education, metabolic health and individualized care